Zobrazeno 1 - 10
of 24
pro vyhledávání: '"P. M. Feorino"'
Autor:
P. M. Feorino, Mark Holodniy, Joe Huong, D. A. Burns, M. Tanner, Mark A. Winters, Belinda Yen-Lieberman, Alan J. Taege, J. L. Wetshtein, Monique R. Ferguson, A. De La Rosa, Daniel R. Mcclernon, W. Armstrong, Robert M. Lloyd, William A. O'Brien, R. L. Mathis, Brian M. Friedrich
Publikováno v:
Journal of Clinical Microbiology. 47:1491-1496
A novel method for the collection and transportation of dried-blood-plasma samples, SampleTanker (ST), was developed and compared to standard shipping protocols for frozen-plasma specimens containing human immunodeficiency virus type 1 (HIV-1) and/or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca14e46ddfb535c50f2593b42b0d6a04
https://doi.org/10.1128/jcm.02354-08
https://doi.org/10.1128/jcm.02354-08
Publikováno v:
Methods in molecular medicine. 24
In the laboratory it is important that potentially pathogenic agents be controlled to protect the laboratory worker from infection and the experiment from contamination. The operation of a safe laboratory depends on many factors: the training and jud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e046fab18a6f550817a2a88d7f37b37
https://pubmed.ncbi.nlm.nih.gov/21331896
https://pubmed.ncbi.nlm.nih.gov/21331896
Publikováno v:
Antiviral Chemistry and Chemotherapy. 4:55-63
The development of a reliable and simple system for evaluating compounds that could prevent activation of latent HIV would allow us to devise new therapeutic approaches. These compounds could eventually be used in combination with drugs that are effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64ea42d7bffa1ab00a8b62436bef2fd5
https://doi.org/10.1177/095632029300400107
https://doi.org/10.1177/095632029300400107
Autor:
M. Holodniy, R. Kantor, P. M. Feorino, C. Loveday, R. L. Mathis, Ricardo Sobhie Diaz, Z. Grossman, Y.W. Tang, R.M. Lloyd
Publikováno v:
Journal of Hepatology. 52:S464
2003 ANTIVIRAL ACTIVITY, PHARMACOKINETICS, AND TOLERABILITY OF AZD7295, A NOVEL NS5A INHIBITOR, IN A PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY IN HCV GENOTYPE 1 AND 3 PATIENTS E. Gane, G.R. Foster, J. Cianciara, C. Stedman, S. Ryder, M. Buti,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a08f9d8ab0e0ec340b57e7c1a7b63af
https://doi.org/10.1016/s0168-8278(10)61195-6
https://doi.org/10.1016/s0168-8278(10)61195-6
Publikováno v:
Infection and Immunity. 29:671-677
Infection of a human lymphoblastoid cell line (F-365 line containing Epstein-Barr viral capsid antigen, derived from an individual without overt signs of lymphoma, infectious mononucleosis, or leukemia) with herpes simplex virus (HSV), maintained and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6fb9da2faf64726d357c5b54801e16
https://doi.org/10.1128/iai.29.2.671-677.1980
https://doi.org/10.1128/iai.29.2.671-677.1980
Publikováno v:
Infection and Immunity. 24:539-544
Infection of a human lymphoblastoid cell line (Jijoye line derived from a Burkitt lymphoma which contains Epstein-Barr virus) with equine herpesvirus 1, maintained and observed for 53 days, was characterized by the continuous production of infectious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a84e7f80af75fd04c20b79bae50b1e
https://doi.org/10.1128/iai.24.2.539-544.1979
https://doi.org/10.1128/iai.24.2.539-544.1979
Publikováno v:
Journal of Clinical Microbiology. 1:429-433
A rapid microradioimmunoassay (RIA) technique was adapted for quantitatively measuring antibody titers to antigens occurring in Epstein-Barr virus (EBV)-infected lymphoid cells. In these experiments two EBV-infected cell lines, HR1K and EB-3, were us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef3889b8ef86160c1b1641e7bdbdc0d
https://doi.org/10.1128/jcm.1.5.429-433.1975
https://doi.org/10.1128/jcm.1.5.429-433.1975
Publikováno v:
Infection and Immunity. 36:841-843
Four independent hybridoma clones have been established that produce neutralizing antibodies specific to type 1 poliovirus. Each clone produced antibody which neutralized a distinct set of type 1 test strains: (i) all 15 strains tested; (ii) the indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eff9132dd8d64d61f930b64615cc24b4
https://doi.org/10.1128/iai.36.2.841-843.1982
https://doi.org/10.1128/iai.36.2.841-843.1982
Autor:
T A, Peterman, G R, Lang, N J, Mikos, S L, Solomon, C A, Schable, P M, Feorino, J A, Britz, J R, Allen
Publikováno v:
JAMA. 255(17)
Twenty-five (4.8%) of 520 hemodialysis patients were seropositive for antibody to human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by enzyme immunoassay. Four had high reactivity on enzyme immunoassay and posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e73acec86412915f7549e5d6660fe924
https://pubmed.ncbi.nlm.nih.gov/3007792
https://pubmed.ncbi.nlm.nih.gov/3007792
Publikováno v:
JAMA. 241(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b013487a8566761d7f5daa2f5be9ff5
https://pubmed.ncbi.nlm.nih.gov/214590
https://pubmed.ncbi.nlm.nih.gov/214590